39 studies found for:    " October 05, 2011":" November 04, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 05, 2011":" November 04, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Maraviroc
2 Terminated
Has Results
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Raltegravir
3 Active, not recruiting A Commitment Device for Medication Adherence Among HIV Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV
Intervention: Other: Medication Adherence among HIV/AIDS Patients
4 Withdrawn Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents
Condition: HIV Infection
Interventions: Dietary Supplement: Probiotics;   Dietary Supplement: Placebo
5 Recruiting Early Antiviral Therapy for Critically Ill HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: early HAART;   Drug: Late HAART
6 Completed Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Darunavir/Ritonavir (DRV/r);   Drug: Lopinavir in fixed combination with Ritonavir;   Drug: Zidovudine;   Drug: NRTIs;   Drug: Efavirenz
7 Completed Problems With Immune Recovery in the Gut Tissue
Condition: Human Immunodeficiency Virus
Intervention: Procedure: Genital and rectal swabbing
8 Active, not recruiting Tissue Drug Levels of HIV Medications
Condition: Human Immunodeficiency Virus
Intervention: Drug: Initiation of anti-retroviral therapy
9 Active, not recruiting
Has Results
Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg OAD;   Drug: darunavir 800mg OAD;   Drug: ritonavir 100mg OAD
10 Active, not recruiting Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section
Condition: Human Immunodeficiency Virus
Intervention:
11 Completed A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects
Condition: Infections, Human Immunodeficiency Virus and Hepatitis
Interventions: Drug: Dolutegravir;   Drug: Rlipivirine;   Drug: GSK1265744
12 Completed Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV
Condition: HIV Infection
Intervention:
13 Unknown  Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos
Conditions: HIV;   AIDS
Intervention: Behavioral: Video or In-Person Presentation
14 Completed A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005)
Condition: HIV-1 Infection
Interventions: Drug: Doravirine;   Drug: Placebo
15 Completed Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho
Conditions: HIV/AIDS;   Tuberculosis;   Diabetes Mellitus;   Arterial Hypertension
Interventions: Other: Door-to-door;   Other: Pitso
16 Completed
Has Results
A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1
Condition: Hepatitis C Virus Genotype-1
Interventions: Drug: TMC435;   Drug: Pegylated interferon alpha-2a;   Drug: Ribavirin
17 Unknown  Bioequivalence Study of Pediatric Formulations to Treat HIV Infection
Conditions: HIV;   AIDS
Interventions: Drug: Epivir®, Retrovir® and Viramune®;   Drug: Lamivudine, Zidovudine and nevirapine;   Drug: Lamivudine, zidovudine, nevirapine
18 Completed The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function
Condition: HIV
Intervention:
19 Active, not recruiting School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
Condition: HIV
Intervention: Behavioral: School Support Intervention
20 Completed Atazanavir/Ritonavir and Zinc Pharmacokinetic Study
Condition: HIV Infection
Interventions: Drug: 1 Solvazinc tablet, day 2 to day 15;   Drug: 1 Solvazinc tablet, day 15 to day 28

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Indicates status has not been verified in more than two years